查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1949189

全球放射腫瘤市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Radiation Oncology Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 141 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計放射腫瘤學市場將從 2025 年的 102.7 億美元成長到 2034 年的 192.5 億美元，2026 年至 2034 年的複合年成長率為 7.23%。

受癌症發病率上升和對有效治療方法需求不斷成長的推動，放射腫瘤市場預計將顯著成長。隨著全球癌症發生率持續攀升，對先進放射治療解決方案的需求日益迫切。放射腫瘤學涵蓋多種技術，包括體外放射治療、近距離放射放射治療和立體定位放射線手術，所有這些技術對於綜合治療各種類型的癌症都至關重要。強度調控放射治療(IMRT) 和影像導航放射治療(IGRT) 等先進技術的整合正在提高治療的精確性和有效性，從而改善患者預後並最大限度地減少副作用。

此外，放射腫瘤學技術的進步正在推動市場創新。質子療法和其他粒子束療法的發展正在革新癌症治療，它們能夠提供標靶放射治療，有效治療腫瘤的同時保護健康組織。這些先進治療方法對兒童患者以及腫瘤位於重要結構附近的患者尤其有益。隨著放射腫瘤學領域新應用和新技術的不斷探索，預計隨著治療效果和患者安全性的提高，市場將進一步擴張。

此外，對個人化醫療的日益重視正在重塑放射腫瘤學的格局。隨著醫療服務提供者基於基因和分子譜分析為每位患者量身定做治療方案，對符合個人化治療計劃的放射線治療的需求預計將會增加。這一趨勢在聯合治療領域尤其重要，聯合治療是指將放射線治療與免疫療法或標靶治療合併使用，以提高治療效果。隨著放射腫瘤學市場的不斷發展，技術創新、個人化治療方法以及對改善患者預後的關注將在其未來發展軌跡中發揮關鍵作用。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球放射腫瘤市場：依產品類型分類

  • 市場分析、洞察與預測
  • 體外放射線治療
  • 內放射線治療
  • 全身放射線治療

第5章：全球放射腫瘤市場：依應用分類

  • 市場分析、洞察與預測
  • 乳癌
  • 肺癌
  • 攝護腺癌
  • 結腸癌
  • 頭頸癌
  • 其他

第6章 全球放射腫瘤市場：依最終用戶分類

  • 市場分析、洞察與預測
  • 醫院
  • 門診放射治療中心
  • 癌症研究機構
  • 其他

第7章 全球放射腫瘤市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第8章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第9章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Siemens Healthineers
    • GE Healthcare
    • Philips Healthcare
    • Varian Medical Systems
    • Elekta
    • Hitachi Medical Corporation
    • IBA Worldwide
    • Accuray Incorporated
    • Advanced Accelerator Applications
    • Nordion Inc
簡介目錄
Product Code: VMR11219481

The Radiation Oncology Market size is expected to reach USD 19.25 Billion in 2034 from USD 10.27 Billion (2025) growing at a CAGR of 7.23% during 2026-2034.

The radiation oncology market is poised for significant growth, driven by the increasing incidence of cancer and the rising demand for effective treatment modalities. As cancer rates continue to escalate globally, the need for advanced radiation therapy solutions is becoming more critical. Radiation oncology encompasses a range of techniques, including external beam radiation therapy, brachytherapy, and stereotactic radiosurgery, all of which are essential in the comprehensive management of various cancer types. The integration of cutting-edge technologies, such as intensity-modulated radiation therapy (IMRT) and image-guided radiation therapy (IGRT), is enhancing the precision and effectiveness of treatment, thereby improving patient outcomes and minimizing side effects.

Moreover, advancements in radiation oncology technologies are driving innovation within the market. The development of proton therapy and other particle therapies is revolutionizing cancer treatment by providing targeted radiation that spares healthy tissues while effectively treating tumors. These advanced modalities are particularly beneficial for pediatric patients and those with tumors located near critical structures. As research continues to explore new applications and techniques in radiation oncology, the market is likely to expand further, fueled by the promise of improved therapeutic efficacy and patient safety.

Additionally, the growing emphasis on personalized medicine is shaping the radiation oncology landscape. As healthcare providers increasingly seek to tailor treatments to individual patients based on genetic and molecular profiling, the demand for radiation therapy that aligns with personalized treatment plans is expected to rise. This trend is particularly relevant in the context of combination therapies, where radiation is used alongside immunotherapy or targeted therapies to enhance treatment effectiveness. As the radiation oncology market continues to evolve, the convergence of technological advancements, personalized treatment approaches, and a focus on improving patient outcomes will play a crucial role in shaping its future trajectory.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

  • External Beam Radiation Therapy
  • Internal Beam Radiation Therapy
  • Systemic Radiation Therapy

By Application

  • Breast Cancer
  • Lung Cancer
  • Prostate Cancer
  • Colorectal Cancer
  • Head and Neck Cancer
  • Others

By End-User

  • Hospitals
  • Ambulatory Radiotherapy Centers
  • Cancer Research Institutes
  • Others

COMPANIES PROFILED

  • Siemens Healthineers, GE Healthcare, Philips Healthcare, Varian Medical Systems, Elekta, Hitachi Medical Corporation, IBA Worldwide, Accuray Incorporated, Advanced Accelerator Applications, Nordion Inc

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL RADIATION ONCOLOGY MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product Type
  • 4.2. External Beam Radiation Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Internal Beam Radiation Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Systemic Radiation Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL RADIATION ONCOLOGY MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Application
  • 5.2. Breast Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Lung Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Prostate Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Colorectal Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.6. Head and Neck Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL RADIATION ONCOLOGY MARKET: BY END-USER 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast End-user
  • 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Ambulatory Radiotherapy Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Cancer Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL RADIATION ONCOLOGY MARKET: BY REGION 2022-2034(USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Product Type
    • 7.2.2 By Application
    • 7.2.3 By End-user
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Product Type
    • 7.3.2 By Application
    • 7.3.3 By End-user
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Product Type
    • 7.4.2 By Application
    • 7.4.3 By End-user
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Product Type
    • 7.5.2 By Application
    • 7.5.3 By End-user
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 South East Asia
    • 7.5.9 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Product Type
    • 7.6.2 By Application
    • 7.6.3 By End-user
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL RADIATION ONCOLOGY INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Siemens Healthineers
    • 9.2.2 GE Healthcare
    • 9.2.3 Philips Healthcare
    • 9.2.4 Varian Medical Systems
    • 9.2.5 Elekta
    • 9.2.6 Hitachi Medical Corporation
    • 9.2.7 IBA Worldwide
    • 9.2.8 Accuray Incorporated
    • 9.2.9 Advanced Accelerator Applications
    • 9.2.10 Nordion Inc